Neurodevelopmental Disorders
From Proteopedia
(Difference between revisions)
| Line 17: | Line 17: | ||
To view [[Neurodevelopmental Disorders]] related proteins which are [[Proteopedia:Structure Index|Structure Index]] entries see: | To view [[Neurodevelopmental Disorders]] related proteins which are [[Proteopedia:Structure Index|Structure Index]] entries see: | ||
| + | *[[Ionotropic_Glutamate_Receptors#3D_structures_of_glutamate_receptor|Ionotropic Glutamate Receptor]] | ||
*[[Methyl_CpG_Binding_Protein_2#Additional_Structures_of_MeCP2|Methyl CpG Binding Protein 2]] | *[[Methyl_CpG_Binding_Protein_2#Additional_Structures_of_MeCP2|Methyl CpG Binding Protein 2]] | ||
*[[Neurexin]] | *[[Neurexin]] | ||
Revision as of 22:12, 25 July 2011
Neurodevelopmental Disorders are various disorders which impair growth and development of the brain and/or central nervous system, often resulting in neurological dysfunction.
Articles in Proteopedia concerning Neurodevelopmental Disorders include:
- Beta-2 Adrenergic Receptor - Involved in Autism
- Ephrin Type-A Receptor - Involved in Tuberous Sclerosis
- FOXP2 - Involved in Speach Disorders
- Ionotropic Glutamate Receptor - Involved in Autism Spectrum Disorders
- Methyl CpG Binding Protein 2 - Involved in Rett Syndrome
- Neuroligin & Neurexin - Involved in Autism
- Potassium Channels
- Serotonin Transporter - Involved in OCD and Autism
- Shank Family Proteins - Involved in 22q13 Deletion Syndrome
To view Neurodevelopmental Disorders related proteins which are Structure Index entries see:
To view automatically seeded indices concerning Neurodevelopmental Disorders See:
To View FDA Approved Treatments for Neurodevelopmental Disorders See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
